PFIZER INC — Director's Dealing 2021

Feb 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2021-01-31

Reporting Person: Fonseca Lidia (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-31	Common Stock	F	6749.0000	$35.9000	Disposed	39747.0000	Direct

Footnotes

F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

F2: Price is the closing price of Pfizer common stock on January 29, 2021.